As is well-known, signet ring cell carcinoma (SRCC) rarely appears as a histological finding in the prostatic tissue. Nevertheless, a differentiation should be made between a primary tumor and a metastatic disease. We describe the case of a 52-year-old man with lower urinary tract symptoms, serum total PSA of 0.2 ng/ml, elevated serum CEA and CA19-9 levels. Two years prior to presentation, he underwent total gastrectomy with histological findings indicating "poor differentiated adenocarcinoma with signetring cell". A palpable nodule was found on digital rectal examination and for this reason. he underwent 12-core transperineal prostate biopsy with a diagnosis of "poor differentiated adenocarcinoma with signet-ring cell and adipose tissue infiltration". Immunohistochemical examinations revealed positivity for PAS, CK7 and CDX-2, focal positivity for CK20 and negativity for PSA and PSAP. The diagnosis of a prostatic secondary SRCC was possible given the positivity to CK7, CDX-2, focal positivity to CK20 and negativity to PSA
Expression of CD7, CD20 and CDX-2 in a secondary signet-ring cell tumor of the prostate: a case report.
CIMINO, SEBASTIANO;RUSSO, GIORGIO IVAN;ZANGHI, Antonino;MORGIA, Giuseppe Maria
2013-01-01
Abstract
As is well-known, signet ring cell carcinoma (SRCC) rarely appears as a histological finding in the prostatic tissue. Nevertheless, a differentiation should be made between a primary tumor and a metastatic disease. We describe the case of a 52-year-old man with lower urinary tract symptoms, serum total PSA of 0.2 ng/ml, elevated serum CEA and CA19-9 levels. Two years prior to presentation, he underwent total gastrectomy with histological findings indicating "poor differentiated adenocarcinoma with signetring cell". A palpable nodule was found on digital rectal examination and for this reason. he underwent 12-core transperineal prostate biopsy with a diagnosis of "poor differentiated adenocarcinoma with signet-ring cell and adipose tissue infiltration". Immunohistochemical examinations revealed positivity for PAS, CK7 and CDX-2, focal positivity for CK20 and negativity for PSA and PSAP. The diagnosis of a prostatic secondary SRCC was possible given the positivity to CK7, CDX-2, focal positivity to CK20 and negativity to PSAFile | Dimensione | Formato | |
---|---|---|---|
Expression of CD7, CD20 and CDX-2.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Dimensione
2.15 MB
Formato
Adobe PDF
|
2.15 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.